National Bank Of Canada Edesa Biotech, Inc. Transaction History

National Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$0.63 - $0.99 $2 - $3	4 Added 7.14%	60 $0
Q1 2023 Apr 12, 2023	SELL	$0.91 - $2.63 $7,229 - $20,892	-7,944 Reduced 99.3%	56 $0
Q4 2022 Jan 24, 2023	BUY	$0.8 - $8.05 $3,200 - $32,200	4,000 Added 100.0%	8,000 $0
Q2 2022 Jul 28, 2022	SELL	$1.47 - $2.94 $8,820 - $17,640	-6,000 Reduced 60.0%	4,000 $6,000
Q1 2022 May 05, 2022	BUY	$2.72 - $5.97 $25,519 - $56,010	9,382 Added 1518.12%	10,000 $30,000
Q4 2021 Jan 24, 2022	BUY	$5.17 - $8.65 $3,195 - $5,345	618 New	618 $3,000

Ticker EDSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,462,300
Market Cap $38.2M
Description
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.